Answers are grounded in this paper and cite their sources.
Clofazimine (B 633), a phenazine derivative with a therapeutic effect against leprosy, has previously been found to stimulate the phagocytic capacity of neutrophilic leucocytes in vitro. The substance was therefore given to 6 patients with chronic myeloid leukaemia and 2 patients with an abnormal chromatin clumping of the neutrophils associated with subnormal phagocytosis. During oral treatment with daily doses of 100–600 mg, the phagocytic capacity of the neutrophilic leucocytes in peripheral blood was increased in all cases. The positive effect was noted between 4 and 11 days after starting the treatment. On prolonged administration of high doses, the enhancement of phagocytosis became less pronounced. Since the drug has proved to be without serious side effects, further investigation of its possible role in conditions associated with subnormal granulocyte function and increased susceptibility to infections would seem justified.
No takes yet. Share an insight, caveat, or question.
L. Brandt (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: